Requirement of Hydrogen Peroxide Generation in TGF-beta 1 Signal Transduction in Human Lung Fibroblast Cells: Involvement of Hydrogen Peroxide and Ca2+ in TGF-beta 1-induced IL-6 Expression
Overview
Authors
Affiliations
Stimulation of human lung fibroblast cells with TGF-beta1 resulted in a transient burst of reactive oxygen species with maximal increase at 5 min after treatment. This reactive oxygen species increase was inhibited by the antioxidant, N-acetyl-l -cysteine (NAC). TGF-beta1 treatment stimulated IL-6 gene expression and protein synthesis in human lung fibroblast cells. Antioxidants including NAC, glutathione, and catalase reduced TGF-beta1-induced IL-6 gene expression, and direct H2O2 treatment induced IL-6 expression in a dose-dependent manner. NAC also reduced TGF-beta1-induced AP-1 binding activity, which is involved in IL-6 gene expression. It has been reported that Ca2+ influx is stimulated by TGF-beta1 treatment. EGTA suppressed TGF-beta1- or H2O2-induced IL-6 expression, and ionomycin increased IL-6 expression, with simultaneously modulating AP-1 activity in the same pattern. PD98059, an inhibitor of mitogen-activated protein kinase (MAPK) kinase/extracellular signal-related kinase kinase 1, suppressed TGF-beta1- or H2O2-induced IL-6 and AP-1 activation. In addition, TGF-beta1 or H2O2 increased MAPK activity which was reduced by EGTA and NAC, suggesting that MAPK is involved in TGF-beta1-induced IL-6 expression. Taken together, these results indicate that TGF-beta1 induces a transient increase of intracellular H2O2 production, which regulates downstream events such as Ca2+ influx, MAPK, and AP-1 activation and IL-6 gene expression.
VanSlyke J, Boswell B, Musil L Mol Biol Cell. 2024; 35(3):ar35.
PMID: 38170570 PMC: 10916858. DOI: 10.1091/mbc.E23-07-0294.
Yang J, Lin W, Tai S, Ciou Y, Chung C, Chen J Int J Mol Sci. 2023; 24(14).
PMID: 37511415 PMC: 10380600. DOI: 10.3390/ijms241411656.
Kim H, Hwang J, Bo Noh K, Oh S, Park J, Shin Y Antioxidants (Basel). 2023; 12(6).
PMID: 37371916 PMC: 10295357. DOI: 10.3390/antiox12061186.
Reghelin C, Bastos M, de Souza Basso B, Costa B, Lima K, Cruz de Sousa A Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3857-3866.
PMID: 37358795 DOI: 10.1007/s00210-023-02595-2.
Rao V, Stubbs Jr E Invest Ophthalmol Vis Sci. 2021; 62(4):4.
PMID: 33821883 PMC: 8039474. DOI: 10.1167/iovs.62.4.4.